Journey Medical (DERM) Operating Income (2020 - 2026)
Journey Medical (DERM) posted Operating Income of -$1.5 million for Q1 2026, down 236.79% on a QoQ basis from -$443000.0 in Q4 2025, and up 55.11% year-over-year from -$961871.2 in Q1 2025.
Journey Medical (DERM) Operating Income (2020 - 2026) Analysis & Trends
Journey Medical's Operating Income history runs 7 years deep, the most recent figure standing at -$1.5 million for Q1 2026.
- Quarterly Operating Income rose 55.11% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.3 million (up 8.26% YoY) and the FY2025 annual result came in at -$8.2 million, up 40.25% from the prior year.
- Operating Income was -$1.5 million for Q1 2026 at Journey Medical, down from -$443000.0 in the prior quarter.
- Across five years, Operating Income topped out at $17.2 million in Q3 2023 and bottomed at -$10.1 million in Q1 2024.
- A 5-year average of -$3.1 million and a median of -$2.9 million in 2024 frame the typical range for Operating Income.
- Peak annual rise in Operating Income reached 281.68% in 2023, while the deepest fall reached 976.69% in 2023.
- Journey Medical's Operating Income stood at -$10.0 million in 2022, then jumped by 78.95% to -$2.1 million in 2023, then soared by 206.18% to $2.2 million in 2024, then plunged by 119.83% to -$443000.0 in 2025, then slumped by 236.79% to -$1.5 million in 2026.
- Business Quant data shows DERM's Operating Income at -$1.5 million in Q1 2026, -$443000.0 in Q4 2025, and -$1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 325.80 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn | -1.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.49 Mn |
| Dec 31, 2025 | -443,000.00 |
| Sep 30, 2025 | -1.53 Mn |
| Jun 30, 2025 | -2.88 Mn |
| Mar 31, 2025 | -3.32 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | -2.89 Mn |
| Jun 30, 2024 | -2.93 Mn |
| Mar 31, 2024 | -10.09 Mn |
| Dec 31, 2023 | -2.10 Mn |
| Sep 30, 2023 | 17.25 Mn |
| Jun 30, 2023 | -7.65 Mn |
| Mar 31, 2023 | -9.56 Mn |
| Dec 31, 2022 | -10.00 Mn |
| Sep 30, 2022 | -9.49 Mn |
| Jun 30, 2022 | -7.14 Mn |
| Mar 31, 2022 | -888,000.00 |
| Dec 31, 2021 | -9.06 Mn |
| Sep 30, 2021 | -12.65 Mn |
| Jun 30, 2021 | -13.76 Mn |